US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% META $741.90 ▲+1.90%
FinancialContent

Articles published by Predictive Oncology Inc.

< Previous 1 2 Next >
News headline image
Predictive Oncology Becomes Axe Compute, Expanding Into High-Performance AI Infrastructure
From Predictive Oncology Inc.
Via GlobeNewswire
News headline image
Predictive Oncology Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
News headline image
Predictive Oncology Reports Third Quarter 2025 Financial Results and Provides Update on Digital Asset Strategy
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
News headline image
Predictive Oncology Announces Additions to Board and Leadership Team to Support Digital Asset Treasury Strategy
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
News headline image
Predictive Oncology Inc. Announces Closing of $343.5 Million in Private Placements to Initiate Digital Asset Treasury Strategy
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
News headline image
Predictive Oncology Inc. Announces Private Placements of $344 Million to Initiate a Digital Asset Treasury Strategy Focused on Aethir (ATH) Tokens
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
News headline image
Predictive Oncology Announces 1-for-15 Reverse Stock Split
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
News headline image
Predictive Oncology and Every Cure Announce a Strategic Collaboration to Pursue Drug Repurposing for Cancer Patients
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
News headline image
Predictive Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
News headline image
Predictive Oncology Issues Shareholder Letter: Well Financed to Support Expanded U.S. Availability and E.U. Launch of ChemoFx® and Pursuit of Other High-Value AI-Driven Drug Discovery and Development Opportunities
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
News headline image
Predictive Oncology Announces $10M Share Purchase Agreement in Partnership with Yorkville Advisors to Advance AI-Driven Drug Discovery and Repurposing
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
News headline image
Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers LH POAI
News headline image
Court Denies Renovaro Motion for an Expedited Trial in July
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
News headline image
AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
News headline image
Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: AI-Driven Biomarker and Drug Discovery for Precision Health"
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
News headline image
Predictive Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
News headline image
Predictive Oncology Develops Novel Approach to Identifying Clinically Viable Abandoned Drugs
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
News headline image
Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
News headline image
Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
News headline image
Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
News headline image
Predictive Oncology Moves to Finalize Definitive Merger Agreement With Renovaro Biosciences
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI RENB
News headline image
Predictive Oncology Closes Registered Direct Offering
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
News headline image
Predictive Oncology Announces Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
News headline image
Predictive Oncology Reports Positive Results Utilizing Artificial Intelligence for Drug Repurposing
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
News headline image
Predictive Oncology Partners with Switzerland-Based Tecan Group Ltd. to Expand High-Throughput Drug Screening to Include Human Tumor Spheroids Using Automated Imaging and 3D Analysis
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
News headline image
Predictive Oncology Announces Planned European Launch of its ChemoFx® Treatment Selection Marker and Tumor Profiling Assay
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
News headline image
Predictive Oncology Announces Agreement to be Acquired by Renovaro
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI RENB
News headline image
Predictive Oncology Announces Progress in Ongoing Evaluation of Strategic Alternatives
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
News headline image
Predictive Oncology Reports Third Quarter 2024 Financial Results and Provides Strategic Update
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
News headline image
Predictive Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
< Previous 1 2 Next >